Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects.
Romito I, Porru M, Braghini MR, Pompili L, Panera N, Crudele A, Gnani D, De Stefanis C, Scarsella M, Pomella S, Levi Mortera S, de Billy E, Conti AL, Marzano V, Putignani L, Vinciguerra M, Balsano C, Pastore A, Rota R, Tartaglia M, Leonetti C, Alisi A. Romito I, et al. Among authors: scarsella m. J Exp Clin Cancer Res. 2021 Nov 16;40(1):364. doi: 10.1186/s13046-021-02154-8. J Exp Clin Cancer Res. 2021. PMID: 34784956 Free PMC article.
Correction to: Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects.
Romito I, Porru M, Braghini MR, Pompili L, Panera N, Crudele A, Gnani D, De Stefanis C, Scarsella M, Pomella S, Mortera SL, de Billy E, Conti AL, Marzano V, Putignani L, Vinciguerra M, Balsano C, Pastore A, Rota R, Tartaglia M, Leonetti C, Alisi A. Romito I, et al. Among authors: scarsella m. J Exp Clin Cancer Res. 2022 Jan 27;41(1):40. doi: 10.1186/s13046-022-02247-y. J Exp Clin Cancer Res. 2022. PMID: 35086550 Free PMC article. No abstract available.
Oncolytic adenovirus and gene therapy with EphA2-BiTE for the treatment of pediatric high-grade gliomas.
Arnone CM, Polito VA, Mastronuzzi A, Carai A, Diomedi FC, Antonucci L, Petrilli LL, Vinci M, Ferrari F, Salviato E, Scarsella M, De Stefanis C, Weber G, Quintarelli C, De Angelis B, Brenner MK, Gottschalk S, Hoyos V, Locatelli F, Caruana I, Del Bufalo F. Arnone CM, et al. Among authors: scarsella m. J Immunother Cancer. 2021 May;9(5):e001930. doi: 10.1136/jitc-2020-001930. J Immunother Cancer. 2021. PMID: 33963009 Free PMC article.
Dysregulated miR-155 and miR-125b Are Related to Impaired B-cell Responses in Down Syndrome.
Farroni C, Marasco E, Marcellini V, Giorda E, Valentini D, Petrini S, D'Oria V, Pezzullo M, Cascioli S, Scarsella M, Ugazio AG, De Vincentiis GC, Grimsholm O, Carsetti R. Farroni C, et al. Among authors: scarsella m. Front Immunol. 2018 Nov 20;9:2683. doi: 10.3389/fimmu.2018.02683. eCollection 2018. Front Immunol. 2018. PMID: 30515165 Free PMC article. Clinical Trial.
69 results